B. Brembilla-perrot et al., Predictors of atrial flutter with 1 : 1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias, INT J CARD, 80(1), 2001, pp. 7-15
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objectives: The purpose of the study was to look for the predictor factors
of atrial proarrhythmic effects of class I antiarrhythmic drugs. Background
: Class I anti arrhythmic drugs may induce or exacerbate cardiac arrhythmia
s. The predictors of ventricular proarrhythmia are known. The predictors of
atrial flutter with 1:1 conduction are unknown. Methods: Clinical history,
EGG, signal-averaged EGG (SAECG) and electrophysiologic study were analyse
d in 24 cases of 1:1 atrial flutter with class I AA drugs and in 100 contro
l patients without history of 1:1 atrial flutter with class I AA drugs. Res
ults: The ages of patients varied from 46 to 78 years. Underlying heart dis
ease was present in nine patients. The surface EGG revealed the presence of
a short PR interval (PR <0.13 ms), visible in leads V5, V6 in eight (35%)
patients with normal P wave duration; in other patients with prolonged P wa
ve duration, PR seemed normaL On SAECG recording, there was a pseudofusion
between P wave and QRS complex. The electrophysiologic study revealed some
signs indicating a rapid AV nodal conduction (short AH interval or rate of
2nd degree AV block at atrial pacing > 200 beats/mm) in 19 of the 23 studie
d patients. All patients, except one, had at least one sign indicating a ra
pid AV nodal conduction (short PR and/or P wave-QRS complex continuity on S
AECG). In the control group, seven patients (7%) had a short PR interval (P
<0.01) and 11 (11%) had a pseudofusion between P wave and QRS complex on S
AECG (P <0.001). The P wave-QRS complex pseudofusion on SAECG had a sensiti
vity of 100% and a specificity of 89% for the prediction of an atrial proar
rhythmic effect with class I antiarrhythmic drug. Conclusion: We recommend
avoiding class I AA drugs in patients with a short PR interval on surface E
GG and to record SAECG in those with apparently normal PR interval to detec
t a continuity between P wave and QRS complex, which could indicate a rapid
AV nodal conduction, predisposing to 1: 1 atrial flutter with the drug. (C
) 2001 Elsevier Science Ireland Ltd. All rights reserved.